Valuation: Bio-View Ltd

Market Cap 11.83M 0 3.88M 3.37M 3.15M 2.89M 5.45M 370M 5.55M 37.15M 14.55M 185M 14.58M 14.26M 609M P/E 2024
-11.7x
P/E 2025 -1.48x
Enterprise Value 7.41M 0 2.43M 2.11M 1.97M 1.81M 3.41M 232M 3.47M 23.25M 9.11M 116M 9.13M 8.93M 381M EV / Sales 2024
1.04x
EV / Sales 2025 0.9x
Free-Float
52.06%
Yield 2024 *
-
Yield 2025 -
1 day+0.23%
1 week-2.64%
Current month-2.10%
1 month-12.89%
3 months-45.03%
6 months-50.56%
Current year-47.01%
1 week 86.6
Extreme 86.6
95.9
1 month 83
Extreme 83
101.7
Current year 83
Extreme 83
294
1 year 83
Extreme 83
294
3 years 83
Extreme 83
370
5 years 83
Extreme 83
480
10 years 83
Extreme 83
515
Manager TitleAgeSince
Corporate Officer/Principal 64 2009-03-21
Director of Finance/CFO 44 2020-11-30
Chief Operating Officer 49 2010-12-31
Director TitleAgeSince
Chairman 87 2000-03-15
Director/Board Member 63 2015-05-31
Director/Board Member 70 2022-06-27
Change 5-day change 1-year change 3-year change Capi.($)
+0.23%-2.64%-62.18%-72.85% 3.88M
+1.44%+3.24%+27.77%-36.92% 16.23B
+4.12%+7.51%+8.10%+116.74% 1.85B
+0.03%+5.23%-22.36%-78.66% 1.21B
+1.63%+0.44%-33.79%+23.58% 972M
+1.73%+5.26%-43.43%-52.03% 666M
-0.55%+5.65%-45.94%-52.30% 540M
+1.01%+8.56%+66.02%-47.37% 502M
+0.78%+3.23%-50.19%-46.62% 390M
+0.41%+3.05%-12.57%-27.77% 369M
Average +1.17%+3.90%-16.86%-27.42% 2.27B
Weighted average by Cap. +1.68%+4.92%+15.87%-25.13%

Financials

2024 2025
Net sales 25.66M 0 8.42M 7.32M 6.83M 6.27M 11.82M 802M 12.03M 80.54M 31.54M 400M 31.62M 30.92M 1.32B 19.93M 0 6.54M 5.68M 5.31M 4.87M 9.18M 623M 9.35M 62.57M 24.5M 311M 24.56M 24.02M 1.03B
Net income -3.15M -0 -1.03M -898K -838K -769K -1.45M -98.46M -1.48M -9.88M -3.87M -49.1M -3.88M -3.79M -162M -15.33M -0 -5.03M -4.37M -4.08M -3.75M -7.07M -480M -7.19M -48.13M -18.85M -239M -18.9M -18.48M -789M
Net Debt -8.96M -0 -2.94M -2.55M -2.38M -2.19M -4.13M -280M -4.2M -28.12M -11.01M -140M -11.04M -10.8M -461M -4.43M -0 -1.45M -1.26M -1.18M -1.08M -2.04M -138M -2.08M -13.89M -5.44M -69.03M -5.46M -5.33M -228M
Logo Bio-View Ltd
Bio-View Ltd. is an Israel-based company that operates within the medical devices industry. The Company focuses on developing, manufacturing, and marketing automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories. One of the key products offered by the Company is the Accord Plus. This product is an automatic fluorescent imaging system that scans, analyzes, and sorts a range of Fluorescence In Situ Hybridization (FISH) and karyotype samples in real-time. The primary goal of this technology is to facilitate the identification of various chromosomal aberrations, such as amplifications, translocations, inversions, and deletions, under fluorescent light.
Employees
30
Date Price Change Volume
26-08-04 ILA 88.50 +0.23% 1,100
26-08-03 ILA 88.30 -2.32% 42,954
26-07-31 ILA 90.40 +0.11% 61
26-07-30 ILA 90.30 +2.03% 19,017
26-07-29 ILA 88.50 -2.64% 40,665
  1. Stock Market
  2. Stocks
  3. BIOV Stock